Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere

Author： Sato Takeo   Hatate Kazuhiko   Ikeda Atsushi   Yamanashi Takahiro   Ozawa Heita   Onosato Wataru   Nakamura Takatoshi   Ihara Atsushi   Watanabe Masahiko  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.7, 2008-05, pp. : 1223-1228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

By Cao Shousong   Bhattacharya Arup   Durrani Farukh A   Fakih Marwan  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 687-703

Informa Healthcare

Access to resources Recommend Favorite

Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer

By Glimelius Bengt  

Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. : 417-433

Adis International

Access to resources Recommend Favorite

Treatment of advanced colorectal cancer reviewed

By  

Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cetuximab launched in Japan for advanced colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer

By  

Current Drug Delivery, Vol. 9, Iss. 2, 2012-03 ,pp. : 122-131

Bentham Science Publishers

Access to resources Recommend Favorite